Verve Therapeutics
VERV
#6018
Rank
HK$7.75 B
Marketcap
HK$86.80
Share price
0.00%
Change (1 day)
125.26%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2025 (TTM): -HK$1.63 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are HK$59.61 Million. In 2024 the company made an earning of -HK$1.79 Billion a decrease over its 2023 earnings that were of -HK$1.75 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$1.63 Billion-9.03%
2024 -HK$1.79 Billion2.48%
2023 -HK$1.75 Billion34.67%
2022 -HK$1.3 Billion90.3%
2021 -HK$0.68 Billion114.31%
2020 -HK$0.32 Billion